Company Executives

$XGN Management Team

Mr. Jeffrey Black

Chief Financial Officer

Corporate Secretary

Age 56

Compensation $1.021M USD

Sex Male

Dr. Tina Nova

Executive Chairman of the Board

Age 71

Compensation $126.9K USD

Sex Female

Mr. John Aballi

President

Chief Executive Officer

Director

Age 40

Compensation $1.185M USD

Sex Male

Name / Title	Age	Compensation	Sex
Mr. Jeffrey Black Chief Financial Officer Corporate Secretary	56	$1.021M USD	Male
Dr. Tina Nova Executive Chairman of the Board	71	$126.9K USD	Female
Mr. John Aballi President Chief Executive Officer Director	40	$1.185M USD	Male

Board of Directors

From the proxy statement filed Apr 27, 2026

Directors

serving now

Independent

5 of 7

stated in the proxy

Average tenure

4.1 years

from year joined

CEO also chairs the board

Tina S. Nova, Ph.D.

Director	Age	On board	Independent	Committees	Other public boards	2025 pay
Tina S. Nova, Ph.D. Board chair	72	2019 7 years	Not independent	None stated	Aurinia Pharmaceuticals Inc.	$198,178
Scott D. Kahn, Ph.D.	66	2024 2 years	Independent	Compensation, Nominating and Governance · Chair	None stated	$130,035
Paul Kim	58	2023 3 years	Independent	Audit Compensation	None stated	$130,035
Frank Stokes	56	2021 5 years	Independent	Audit · Chair Nominating and Governance	None stated	$126,285
John Aballi CEO	41	2022 4 years	Not independent	None stated	None stated	Paid as CEO
Bruce C. Robertson, Ph.D.	63	2019 7 years	Independent	Compensation Nominating and Governance	None stated	Not stated
Charles S. McKhann	57	2025 1 year	Independent	Audit Compensation · Chair	Envoy Medical, Inc.	$87,600

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 27, 2026 states there were none.

Read it in the proxy

Comments